NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 06, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) announces that, on ...
On March 5, 2025, the Company received a written notification (the "Notice”) from the Panel confirming it has granted the Company such an extension for the Company to regain compliance with the MVPHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results